Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Post by lovingstocks23on Sep 12, 2020 1:59pm
239 Views
Post# 31548584

Current situation

Current situationSo if I understand correctly, sticks got the green light but provinces are slow af to order or finalize all the paperwork. We started Q4 with our single largest purchase order of 550k. We got kiss being shipped in 3 provinces. A very good balance sheet (compared to Aurora 1B write-off). There's still 6.8M shares that they still need to purchase in their normal course issuer bid. 

I think we should start to see the market's interest in the company if the company can demonstrate solid expense management and positive EBITDA. In two months we should get an update over the new 2.0 products and add to that potential US legalization.  

We should prepare to load up some more shares because we're in the last days of the stock trading sub 20 cents. 

Yes we are a small LP, but if they can demonstrate you can produce solid margins with a small facility when others are failing, they could raise more equity and replicate with second growing facility. 

What do you guys ? Where do you see THC going till the end of 2020 ?
<< Previous
Bullboard Posts
Next >>